PT

Dados B3 › Restatements

Has VITRU EDUCAÇÃO S.A. (VTRU3) ever restated its financial statements? In which years?

Yes: the statements for 2022, 2023 came back with different figures in the following year's annual filing — 10 account(s) in all, each below with both values.

YearAccountAs first filedAs restatedDifferenceRevealed in (CVM file)
2022long-term borrowings (BPP 2.02.01)R$ 1.49 bnR$ 0 k100.0%DFP 2023 · 27/08/2024
2022net income plus OCI (DMPL 5.05)R$ 0 kR$ 93.1 m100.0%DFP 2023 · 27/08/2024
2022profit in the statement of changes in equity (DMPL 5.05.01)R$ 0 kR$ 93.1 m100.0%DFP 2023 · 27/08/2024
2022internal changes in equity (DMPL 5.06)R$ 93.1 mR$ 0 k100.0%DFP 2023 · 27/08/2024
2022short-term borrowings (BPP 2.01.04)R$ 131.1 mR$ 1.62 bn91.9%DFP 2023 · 27/08/2024
2022current liabilities (BPP 2.01)R$ 145.7 mR$ 1.63 bn91.1%DFP 2023 · 27/08/2024
2022current assets (BPA 1.01)R$ 116.7 mR$ 117.4 m0.5%DFP 2023 · 27/08/2024
2023short-term borrowings (BPP 2.01.04)R$ 1.51 bnR$ 151.1 m90.0%DFP 2024 · 25/03/2025
2023current liabilities (BPP 2.01)R$ 1.56 bnR$ 208.8 m86.6%DFP 2024 · 25/03/2025
2023long-term borrowings (BPP 2.02.01)R$ 676.6 mR$ 2.03 bn66.7%DFP 2024 · 25/03/2025

How it is detected: each year appears twice at the CVM — in its own annual filing and as the comparative in the next one. A difference above 0.5% in a key account is recorded, never corrected silently. Only the aggregation the site publishes (consolidated, or individual when the company does not consolidate) counts. Descriptive, not investment advice.

VTRU3 — company page · all restatements in the base

Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-27 00:00 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-27 00:00 UTC. If this does not match /saude, you are reading a cached copy.